BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bolton Medical Obtains CE Mark for the New RELAY Plus Thoracic Stent-Graft Delivery System


4/23/2009 8:03:19 AM

SUNRISE, FL--(MARKET WIRE)--Apr 22, 2009 -- At the recent Charing Cross Symposium in London, Bolton Medical announced the launch of a new and further improved delivery system: RELAY Plus. The new delivery system is designed for use with the highly successful RELAY Thoracic Stent-Graft and offers some key new features:

-- Hydrophilic coating on outer sheath and tip for easier introduction and advancement through the aorta

-- Longer 60cm braided outer sheath with enhanced radiopacity and reinforced pushrod provides improved push ability and visibility in challenging aortic anatomies

-- New nitinol inner catheter provides improved self alignment of the dual sheath system

RELAY Plus was CE marked in March 2009 and is available in Europe and all countries that recognize CE mark certification. It will be marketed along with the RELAY Thoracic Stent-Graft which was launched in Europe in 2005 and is well underway in clinical trials in the US.

RELAY and RELAY NBS Endovascular Stent-Grafts are indicated for the treatment of main thoracic aortic pathologies such as aneurysms, dissections, penetrating ulcers, pseudoaneurysms and intramural haematoma in adult patients. It is expected that by the end of 2009 more than 3000 RELAY and RELAY NBS Stent Grafts will have been implanted worldwide.

Thoracic Stent-Grafts are an option to traditional open surgery for patients requiring treatment for main thoracic pathologies. The endovascular stent-graft procedure generally results in a reduced hospital stay and a shorter recovery time for patients. This can provide a considerable advantage in care given that the majority of patients who require this treatment are seniors.

COMPANY

Bolton Medical is a private company with European operations based in Barcelona, Spain and US operations in Sunrise, Florida. Bolton Medical is wholly owned subsidiary of Werfen Life Group, a diverse manufacturer and supplier of products for the medical industry.

Contact:

PR Contact: USA: Candace DeLeonardis (001) 954-636-9785

EU and other countries: Carlos Camps + 34 93.817.63.10



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES